Article
Granulocyte-macrophage colony-stimulating factor augments lymphokine-activated killer activity from pleural cavity mononuclear cells of lung cancer patients without malignant effusion.
Japanese journal of cancer research : Gann - 1 Sept 1995
Takahashi K, Sone S, Saito S, Kamamura Y, Uyama T, Ogura T, Monden Y
Abstract excerpt
The role of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) in augmentation of lymphokine-activated killer (LAK) cell induction by interleukin-2 (IL-2) from pleural cavity mononuclear cells (PCMNCs) was examined in sixteen patients with resectable primary lung cancer not ass...
Topics
- Aged
- Female
- Granulocyte-Macrophage Colony-Stimulating Factor
- Humans
- Immunotherapy, Adoptive
- Interleukin-2
- Killer Cells, Lymphokine-Activated
- Leukocytes, Mononuclear
- Lung Neoplasms
- Male
- Middle Aged
- Phenotype
- Pleura
- Pleural Effusion, Malignant